Abstract
Muscle wasting is one of the major health problems in older adults and is traditionally associated to sarcopenia. Nonetheless, muscle loss may also occur in older adults in the presence of cancer, and in this case, it is associated to cancer cachexia. The clinical management of these conditions is a challenge due to, at least in part, the difficulties in their differential diagnosis. Thus, efforts have been made to better comprehend the pathogenesis of sarcopenia and cancer cachexia, envisioning the improvement of their clinical discrimination and treatment. To add insights on this topic, this review discusses the current knowledge on key molecular players underlying sarcopenia and cancer cachexia in a comparative perspective. Data retrieved from this analysis highlight that while sarcopenia is characterized by the atrophy of fast-twitch muscle fibers, in cancer cachexia an increase in the proportion of fast-twitch fibers appears to happen. The molecular drivers for these specificmuscle remodeling patterns are still unknown; however, among the predominant contributors to sarcopenia is the age-induced neuromuscular denervation, and in cancer cachexia, the muscle disuse experienced by cancer patients seems to play an important role. Moreover, inflammation appears to be more severe in cancer cachexia. Impairment of nutrition-related mediators may also contribute to sarcopenia and cancer cachexia, being distinctly modulated in each condition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aare S, Spendiff S, Vuda M et al (2016) Failed reinnervation in aging skeletal muscle. Skelet Muscle 6:29. https://doi.org/10.1186/s13395-016-0101-y
Advani SM, Advani PG, VonVille HM, Jafri SH (2018) Pharmacological management of cachexia in adult cancer patients: a systematic review of clinical trials. BMC Cancer 18:1174. https://doi.org/10.1186/s12885-018-5080-4
Al-Majid S, McCarthy DO (2001) Resistance exercise training attenuates wasting of the extensor digitorum longus muscle in mice bearing the colon-26 adenocarcinoma. Biol Res Nurs 2:155–166. https://doi.org/10.1177/109980040100200301
Ali S, Garcia JM (2014) Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options. Gerontology 60:294–305. https://doi.org/10.1159/000356760
Antoun S, Raynard B (2018) Muscle protein anabolism in advanced cancer patients: response to protein and amino acids support, and to physical activity. Ann Oncol 29:ii10–ii17. https://doi.org/10.1093/annonc/mdx809
Aoyagi T, Terracina KP, Raza A et al (2015) Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol 7:17–29. https://doi.org/10.4251/wjgo.v7.i4.17
Apel PJ, Alton T, Northam C et al (2009) How age impairs the response of the neuromuscular junction to nerve transection and repair: an experimental study in rats. J Orthop Res 27:385–393. https://doi.org/10.1002/jor.20773
Arends J, Bachmann P, Baracos V et al (2017) ESPEN guidelines on nutrition in cancer patients. Clin Nutr 36:11–48. https://doi.org/10.1016/j.clnu.2016.07.015
Argilés JM (2005) Cancer-associated malnutrition. Eur J Oncol Nurs 9:S39–S50. https://doi.org/10.1016/j.ejon.2005.09.006
Argilés JM, Betancourt A, Guàrdia-Olmos J et al (2017) Validation of the CAchexia SCOre (CASCO). Staging cancer patients: the use of miniCASCO as a simplified tool. Front Physiol. https://doi.org/10.3389/fphys.2017.00092
Argilés JM, Busquets S, López-Soriano FJ et al (2012) Are there any benefits of exercise training in cancer cachexia? J Cachexia Sarcopenia Muscle 3:73–76. https://doi.org/10.1007/s13539-012-0067-5
Argilés JM, Busquets S, Moore-Carrasco R, López-Soriano FJ (2006) The role of cytokines in cancer cachexia. In: Mantovani G, Anker SD, Inui A et al (eds) Cachexia and wasting: a modern approach. Springer, Milano, pp 467–475
Argilés JM, López-Soriano FJ, Stemmler B, Busquets S (2019) Therapeutic strategies against cancer cachexia. Eur J Transl Myol 29:4–13. https://doi.org/10.4081/ejtm.2019.7960
Ascenzi F, Barberi L, Dobrowolny G et al (2019) Effects of IGF-1 isoforms on muscle growth and sarcopenia. Aging Cell 18:e12954. https://doi.org/10.1111/acel.12954
Azeemuddin MM, Rao CM, Rafiq M et al (2019) Pharmacological investigation of ‘HIM-CHX’: a herbal combination in the experimental muscle wasting condition. Exp Gerontol 125:110663. https://doi.org/10.1016/j.exger.2019.110663
Baar MP, Perdiguero E, Muñoz-Cánoves P, de Keizer PL (2018) Musculoskeletal senescence: a moving target ready to be eliminated. Curr Opin Pharmacol 40:147–155. https://doi.org/10.1016/j.coph.2018.05.007
Bae T, Jang J, Lee H et al (2020) Paeonia lactiflora root extract suppresses cancer cachexia by down-regulating muscular NF-κB signalling and muscle-specific E3 ubiquitin ligases in cancer-bearing mice. J Ethnopharmacol 246:112222. https://doi.org/10.1016/j.jep.2019.112222
Baguet A, Everaert I, Hespel P et al (2011) A new method for non-invasive estimation of human muscle fiber type composition. PLoS One 6:e21956. https://doi.org/10.1371/journal.pone.0021956
Baracos VE, Martin L, Korc M et al (2018) Cancer-associated cachexia. Nat Rev Dis Prim 4:17105. https://doi.org/10.1038/nrdp.2017.105
Baspinar S, Bircan S, Ciris M et al (2017) Expression of NGF, GDNF and MMP-9 in prostate carcinoma. Pathol Res Pract 213:483–489. https://doi.org/10.1016/j.prp.2017.02.007
Bassel-Duby R, Olson EN (2006) Signaling pathways in skeletal muscle remodeling. Annu Rev Biochem 75:19–37. https://doi.org/10.1146/annurev.biochem.75.103004.142622
Bauer J, Biolo G, Cederholm T et al (2013) Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE study group. J Am Med Dir Assoc 14:542–559. https://doi.org/10.1016/j.jamda.2013.05.021
Becker C, Lord SR, Studenski SA et al (2015) Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol 3:948–957. https://doi.org/10.1016/S2213-8587(15)00298-3
Beckwée D, Delaere A, Aelbrecht S et al (2019) Exercise interventions for the prevention and treatment of sarcopenia. A systematic umbrella review. J Nutr Heal Aging 23:494–502. https://doi.org/10.1007/s12603-019-1196-8
Bergen IIIHR, Farr JN, Vanderboom PM et al (2015) Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay. Skelet Muscle. https://doi.org/10.1186/s13395-015-0047-5
Bilir C, Engin H, Can M et al (2015) The prognostic role of inflammation and hormones in patients with metastatic cancer with cachexia. Med Oncol 32:56. https://doi.org/10.1007/s12032-015-0497-y
Bing C, Taylor S, Tisdale MJ, Williams G (2001) Cachexia in MAC16 adenocarcinoma: suppression of hunger despite normal regulation of leptin, insulin and hypothalamic neuropeptide Y. J Neurochem 79:1004–1012. https://doi.org/10.1046/j.1471-4159.2001.00639.x
Bloom I, Shand C, Cooper C et al (2018) Diet quality and sarcopenia in older adults: a systematic review. Nutrients 10:308. https://doi.org/10.3390/nu10030308
Boehm I, Miller J, Wishart TM et al (2020) Neuromuscular junctions are stable in patients with cancer cachexia. J Clin Invest 130:1461–1465. https://doi.org/10.1172/JCI128411
Borras C, Ingles M, Mas-Bargues C et al (2020) Centenarians: an excellent example of resilience for successful ageing. Mech Ageing Dev 186:111199. https://doi.org/10.1016/j.mad.2019.111199
Botelho M, Cavadas C (2015) Neuropeptide Y: an anti-aging player? Trends Neurosci 38:701–711. https://doi.org/10.1016/j.tins.2015.08.012
Bowen TS, Schuler G, Adams V (2015) Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J Cachexia Sarcopenia Muscle 6:197–207. https://doi.org/10.1002/jcsm.12043
Brocca L, Cannavino J, Coletto L et al (2012) The time course of the adaptations of human muscle proteome to bed rest and the underlying mechanisms. J Physiol 590:5211–5230. https://doi.org/10.1113/jphysiol.2012.240267
Brown JL, Lee DE, Rosa-Caldwell ME et al (2018) Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice. J Cachexia Sarcopenia Muscle 9:987–1002. https://doi.org/10.1002/jcsm.12354
Bye A, Wesseltoft-Rao N, Iversen PO et al (2016) Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer. Med Oncol 33:54. https://doi.org/10.1007/s12032-016-0768-2
Callahan DM, Tourville TW, Miller MS et al (2015) Chronic disuse and skeletal muscle structure in older adults: sex-specific differences and relationships to contractile function. Am J Physiol - Cell Physiol 308:C932–C943. https://doi.org/10.1152/ajpcell.00014.2015
Campbell WW, Trappe TA, Wolfe RR, Evans WJ (2001) The recommended dietary allowance for protein may not be adequate for older people to maintain skeletal muscle. J Gerontol - Ser A Biol Sci Med Sci 56A:M373–M380. https://doi.org/10.1093/gerona/56.6.m373
Carlson BM, Dedkov EI, Borisov AB, Faulkner JA (2001) Skeletal muscle regeneration in very old rats. Journals Gerontol - Ser A Biol Sci Med Sci 56A:224–233. https://doi.org/10.1093/gerona/56.5.b224
Carnac G, Vernus B, Bonnieu A (2007) Myostatin in the pathophysiology of skeletal muscle. Curr Genomics 8:415–422. https://doi.org/10.2174/138920207783591672
Carosio S, Berardinelli MG, Aucello M, Musarò A (2011) Impact of ageing on muscle cell regeneration. Ageing Res Rev 10:35–42. https://doi.org/10.1016/j.arr.2009.08.001
Cella PS, Marinello PC, Borges FH et al (2019) Creatine supplementation in Walker-256 tumor-bearing rats prevents skeletal muscle atrophy by attenuating systemic inflammation and protein degradation signaling. Eur J Nutr. https://doi.org/10.1007/s00394-019-01933-6
Cerri AP, Bellelli G, Mazzone A et al (2015) Sarcopenia and malnutrition in acutely ill hospitalized elderly: prevalence and outcomes. Clin Nutr 34:745–751. https://doi.org/10.1016/j.clnu.2014.08.015
Chan R, Leung J, Woo J (2016) A prospective cohort study to examine the association between dietary patterns and sarcopenia in chinese community-dwelling older people in Hong Kong. J Am Med Dir Assoc 17:336–342. https://doi.org/10.1016/j.jamda.2015.12.004
Chance WT, Balasubramaniam A, Dayal R et al (1994) Hypothalamic concentration and release of neuropeptide Y into microdialysates is reduced in anorectic tumor-bearing rats. Life Sci 54:1869–1874. https://doi.org/10.1016/0024-3205(94)90144-9
Chance WT, Balasubramaniam A, Thompson H et al (1996) Assessment of feeding response of tumor-bearing rats to hypothalamic injection and infusion of neuropeptide Y. Peptides 17:797–801. https://doi.org/10.1016/0196-9781(96)00108-8
Chance WT, van Lammeren FM, Chen MH et al (1984) Plasma and brain cholecystokinin. J Surg Res 36:490–498. https://doi.org/10.1016/0022-4804(84)90131-8
Chatindiara I, Sheridan N, Kruger M, Wham C (2020) Eating less the logical thing to do? Vulnerability to malnutrition with advancing age: a qualitative study. Appetite 146:104502. https://doi.org/10.1016/j.appet.2019.104502
Chiodera P, Volpi R, Pilla S et al (2000) Decline in circulating neuropeptide Y levels in normal elderly human subjects. Eur J Endocrinol 143:715–716. https://doi.org/10.1530/eje.0.1430715
Cho Y, Kim JW, Keum KC et al (2018) Prognostic significance of sarcopenia with inflammation in patients with head and neck cancer who underwent definitive chemoradiotherapy. Front Oncol. https://doi.org/10.3389/fonc.2018.00457
Cole CL, Kleckner IR, Jatoi A et al (2018) The role of systemic inflammation in cancer-associated muscle wasting and rationale for exercise as a therapeutic intervention. JCSM Clin Reports 3:e00065
Coppola JD, Horwitz BA, Hamilton J, McDonald RB (2004) Expression of NPY Y1 and Y5 receptors in the hypothalamic paraventricular nucleus of aged Fischer 344 rats. Am J Physiol - Regul Integr Comp Physiol 287:R69–R75. https://doi.org/10.1152/ajpregu.00607.2003
Covault J, Sanes JR (1985) Neural cell adhesion molecule (N-CAM) accumulates in denervated and paralyzed skeletal muscles. Proc Natl Acad Sci U S A 82:4544–4548. https://doi.org/10.1073/pnas.82.13.4544
Cox NJ, Ibrahim K, Sayer AA et al (2019) Assessment and treatment of the anorexia of aging: a systematic review. Nutrients 11:144. https://doi.org/10.3390/nu11010144
Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised european consensus on definition and diagnosis. Age Ageing 48:16–31. https://doi.org/10.1093/ageing/afy169
Dalle S, Rossmeislova L, Koppo K (2017) The role of inflammation in age-related sarcopenia. Front Physiol. https://doi.org/10.3389/fphys.2017.01045
Daou N, Hassani M, Matos E et al (2020) Displaced myonuclei in cancer cachexia suggest altered innervation. Int J Mol Sci 21:1092. https://doi.org/10.3390/ijms21031092
de Castro GS, Correia-Lima J, Simoes E et al (2020) Myokines in treatment-naïve patients with cancer-associated cachexia. Clin Nutr. https://doi.org/10.1016/j.clnu.2020.10.050
Degens H, Alway SE (2006) Control of muscle size during disuse, disease, and aging. Int J Sports Med 27:94–99. https://doi.org/10.1055/s-2005-837571
Desgeorges MM, Devillard X, Toutain J et al (2017) Pharmacological inhibition of myostatin improves skeletal muscle mass and function in a mouse model of stroke. Sci Rep. https://doi.org/10.1038/s41598-017-13912-0
Deutz NEP, Ashurst I, Ballesteros MD et al (2019) The underappreciated role of low muscle mass in the management of malnutrition. J Am Med Dir Assoc 20:22–27. https://doi.org/10.1016/j.jamda.2018.11.021
Di Francesco V, Zamboni M, Dioli A et al (2005) Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons. J Gerontol - Ser A Biol Sci Med Sci 60A:1581–1585. https://doi.org/10.1093/gerona/60.12.1581
Diffee GM, Kalfas K, Al-Majid S, McCarthy DO (2002) Altered expression of skeletal muscle myosin isoforms in cancer cachexia. Am J Physiol - Cell Physiol 283:C1376–C1382. https://doi.org/10.1152/ajpcell.00154.2002
Dunne RF, Loh KP, Williams GR et al (2019) Cachexia and sarcopenia in older adults with cancer: a comprehensive review. Cancers (Basel) 11:1861. https://doi.org/10.3390/cancers11121861
Ebner N, Anker SD, von Haehling S (2019) Recent developments in the field of cachexia, sarcopenia, and muscle wasting: highlights from the 11th Cachexia conference. J Cachexia Sarcopenia Muscle 10:218–225. https://doi.org/10.1002/jcsm.12408
Elliott B, Renshaw D, Getting S, Mackenzie R (2012) The central role of myostatin in skeletal muscle and whole body homeostasis. Acta Physiol 205:324–340. https://doi.org/10.1111/j.1748-1716.2012.02423.x
Ezeoke CC, Morley JE (2015) Pathophysiology of anorexia in the cancer cachexia syndrome. J Cachexia Sarcopenia Muscle 6:287–302. https://doi.org/10.1002/jcsm.12059
Fearon K, Strasser F, Anker SD et al (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489–495. https://doi.org/10.1016/S1470-2045(10)70218-7
Fialka-Moser V, Crevenna R, Korpan M, Quittan M (2003) Cancer rehabilitation. Particularly with aspects on physical impairments. J Rehabil Med 35:153–162. https://doi.org/10.1080/16501970310000511
Fischer CP (2006) Interleukin-6 in acute exercise and training: what is the biological relevance? Exerc Immunol Rev 12:6–33
Fontes-Oliveira CC, Busquets S, Toledo M et al (2013) Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency? Biochim Biophys Acta 1830:2770–2778. https://doi.org/10.1016/j.bbagen.2012.11.009
Garcia JM, Garcia-Touza M, Hijazi RA et al (2005) Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 90:2920–2926. https://doi.org/10.1210/jc.2004-1788
Gibson JNA, Halliday D, Morrison WL et al (1987) Decrease in human quadriceps muscle protein turnover consequent upon leg immobilization. Clin Sci 72:503–509. https://doi.org/10.1042/cs0720503
Gillon A, Sheard P (2015) Elderly mouse skeletal muscle fibres have a diminished capacity to upregulate NCAM production in response to denervation. Biogerontology 16:811–823. https://doi.org/10.1007/s10522-015-9608-6
Gleeson M, Bishop NC, Stensel DJ et al (2011) The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 11:607–610. https://doi.org/10.1038/nri3041
Gomes M, Figueiredo D, Teixeira L et al (2017) Physical inactivity among older adults across Europe based on the SHARE database. Age Ageing 46:71–77. https://doi.org/10.1093/ageing/afw165
Greising SM, Ermilov LG, Sieck GC, Mantilla CB (2015) Ageing and neurotrophic signalling effects on diaphragm neuromuscular function. J Physiol 593:431–440. https://doi.org/10.1113/jphysiol.2014.282244
Guttridge DC, Mayo MW, Madrid LV et al (2000) NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289:2363–2366. https://doi.org/10.1126/science.289.5488.2363
Ham DJ, Börsch A, Lin S et al (2020) The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia. Nat Commun 11:4510. https://doi.org/10.1038/s41467-020-18140-1
Han Y-Q, Ming S-L, Wu H-T et al (2018) Myostatin knockout induces apoptosis in human cervical cancer cells via elevated reactive oxygen species generation. Redox Biol 19:412–428. https://doi.org/10.1016/j.redox.2018.09.009
Hardee JP, Counts BR, Carson JA (2019) Understanding the role of exercise in cancer cachexia therapy. Am J Lifestyle Med 13:46–60. https://doi.org/10.1177/1559827617725283
Hardee JP, Lynch GS (2019) Current pharmacotherapies for sarcopenia. Expert Opin Pharmacother 20:1645–1657. https://doi.org/10.1080/14656566.2019.1622093
Hayot M, Michaud A, Koechlin C et al (2005) Skeletal muscle microbiopsy: a validation study of a minimally invasive technique. Eur Respir J 25:431–440. https://doi.org/10.1183/09031936.05.00053404
Hepple RT, Rice CL (2016a) Innervation and neuromuscular control in ageing skeletal muscle. J Physiol 594:1965–1978. https://doi.org/10.1113/JP270561
Hepple RT, Rice CL (2016b) Innervation and neuromuscular control in ageing skeletal muscle. J Physiol 594:1965–1978. https://doi.org/10.1113/JP270561
Heywood R, McCarthy AL, Skinner TL (2018) Efficacy of exercise interventions in patients with advanced cancer: a systematic review. Arch Phys Med Rehabil 99:2595–2620. https://doi.org/10.1016/j.apmr.2018.04.008
Hida T, Imagama S, Ando K et al (2018) Sarcopenia and physical function are associated with inflammation and arteriosclerosis in community-dwelling people: the Yakumo study. Mod Rheumatol 28:345–350. https://doi.org/10.1080/14397595.2017.1349058
Hope K, Ferguson M, Reidlinger DP, Agarwal E (2017) “I don’t eat when I’m sick”: older people’s food and mealtime experiences in hospital. Maturitas 97:6–13. https://doi.org/10.1016/j.maturitas.2016.12.001
Hou Y-C, Wang C-J, Chao Y-J et al (2018) Elevated serum interleukin-8 level correlates with cancer-related cachexia and sarcopenia: an indicator for pancreatic cancer outcomes. J Clin Med 7:502. https://doi.org/10.3390/jcm7120502
Isidori AM, Strollo F, Morè M et al (2000) Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 85:1954–1962. https://doi.org/10.1210/jcem.85.5.6572
Janssen HCJP, Samson MM, Verhaar HJJ (2002) Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 75:611–615. https://doi.org/10.1093/ajcn/75.4.611
Jaul E, Barron J (2017) Age-related diseases and clinical and public health implications for the 85 years old and over population. Front Public Heal 5:335. https://doi.org/10.3389/fpubh.2017.00335
Joanisse S, Nederveen JP, Snijders T et al (2016) Skeletal muscle regeneration, repair and remodelling in aging: the importance of muscle stem cells and vascularization. Gerontology 63:91–100. https://doi.org/10.1159/000450922
Johns N, Hatakeyama S, Stephens NA et al (2014) Clinical classification of cancer cachexia: phenotypic correlates in human skeletal muscle. PLoS One 9:e83618. https://doi.org/10.1371/journal.pone.0083618
Joyce NC, Oskarsson B, Jin L (2015) Muscle biopsy evaluation in neuromuscular disorders. Phys Med Rehabil Clin N Am 23:609–631. https://doi.org/10.1016/j.pmr.2012.06.006
Karin M, Ben-Neriah Y (2000) Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol 18:621–663. https://doi.org/10.1146/annurev.immunol.18.1.621
Katsanos CS, Kobayashi H, Sheffield-Moore M et al (2006) A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am J Physiol - Endocrinol Metab 291:E381–E387. https://doi.org/10.1152/ajpendo.00488.2005
Khatib MN, Shankar AH, Kirubakaran R et al (2018) Ghrelin for the management of cachexia associated with cancer. Cochrane Database Syst Rev CD012229. https://doi.org/10.1002/14651858.CD012229
Kim HO, Kim H-S, Youn J-C et al (2011) Serum cytokine profiles in healthy young and elderly population assessed using multiplexed bead-based immunoassays. J Transl Med 9:113. https://doi.org/10.1186/1479-5876-9-113
Kitagawa M, Haji S, Amagai T (2017) Elevated serum AA/EPA ratio as a predictor of skeletal muscle depletion in cachexic patients with advanced gastro-intestinal cancers. In Vivo (Brooklyn) 31:1003–1009. https://doi.org/10.21873/invivo.11161
Kortebein P, Symons TB, Ferrando A et al (2008) Functional impact of 10 days of bed rest in healthy older adults. Journals Gerontol - Ser A Biol Sci Med Sci 63A:1076–1081. https://doi.org/10.1093/gerona/63.10.1076
Kuo IY, Ehrlich BE (2015) Signaling in muscle contraction. Cold Spring Harb Perspect Biol 7:a006023. https://doi.org/10.1101/cshperspect.a006023
Kweder H, Eidi H (2018) Vitamin D deficiency in elderly: risk factors and drugs impact on vitamin D status. Avicenna J Med 8:139–146. https://doi.org/10.4103/ajm.AJM_20_18
Kwon YN, Yoon SS (2017) Sarcopenia: neurological point of view. J Bone Metab 24:83–89. https://doi.org/10.11005/jbm.2017.24.2.83
Landi F, Marzetti E, Liperoti R et al (2013) Nonsteroidal anti-inflammatory drug (NSAID) use and sarcopenia in older people: results from the ilSIRENTE study. J Am Med Dir Assoc 14:626e9-626e13. https://doi.org/10.1016/j.jamda.2013.04.012
LeBrasseur NK, Schelhorn TM, Bernardo BL et al (2009) Myostatin inhibition enhances the effects of exercise on performance and metabolic outcomes in aged mice. J Gerontol - Ser A Biol Sci Med Sci 64A:940–948. https://doi.org/10.1093/gerona/glp068
Li C, Yu K, Shyh-Chang N et al (2019) Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention. J Cachexia Sarcopenia Muscle 10:586–600. https://doi.org/10.1002/jcsm.12417
Li J, Ito M, Ohkawara B et al (2018) Differential effects of spinal motor neuron-derived and skeletal muscle-derived Rspo2 on acetylcholine receptor clustering at the neuromuscular junction. Sci Rep. https://doi.org/10.1038/s41598-018-31949-7
Li M, Larsson L (2010) Force-generating capacity of human myosin isoforms extracted from single muscle fibre segments. J Physiol 588:5105–5114. https://doi.org/10.1113/jphysiol.2010.199067
Lima JDCC, Simoes E, de Castro G et al (2019) Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia. J Cachexia Sarcopenia Muscle. https://doi.org/10.1002/jcsm.12441
Litterini AJ, Fieler VK, Cavanaugh JT, Lee JQ (2013) Differential effects of cardiovascular and resistance exercise on functional mobility in individuals with advanced cancer: a randomized trial. Arch Phys Med Rehabil 94:2329–2335. https://doi.org/10.1016/j.apmr.2013.06.008
Liu D, Qiao X, Ge Z et al (2019) IMB0901 inhibits muscle atrophy induced by cancer cachexia through MSTN signaling pathway. Skelet Muscle. https://doi.org/10.1186/s13395-019-0193-2
Loumaye A, de Barsy M, Nachit M et al (2015) Role of activin A and myostatin in human cancer cachexia. J Clin Endocrinol Metab 100:2030–2038. https://doi.org/10.1210/jc.2014-4318
Loumaye A, de Barsy M, Nachit M et al (2017) Circulating activin A predicts survival in cancer patients. J Cachexia Sarcopenia Muscle 8:768–777. https://doi.org/10.1002/jcsm.12209
MacIntosh CG, Andrews JM, Jones KL et al (1999) Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation appetite and pyloric motility. Am J Clin Nutr 69:999–1006. https://doi.org/10.1093/ajcn/69.5.999
MacIntosh CG, Morley JE, Wishart J et al (2001) Effect of exogenous cholecystokinin (CCK)-8 on food intake and plasma CCK, leptin, and insulin concentrations in older and young adults: evidence for increased CCK activity as a cause of the anorexia of aging. J Clin Endocrinol Metab 86:5830–5837. https://doi.org/10.1210/jcem.86.12.8107
Mahmassani ZS, Reidy PT, McKenzie AI et al (2019) Age-dependent skeletal muscle transcriptome response to bed rest-induced atrophy. J Appl Physiol 126:894–902
McClure R, Villani A (2017) Mediterranean diet attenuates risk of frailty and sarcopenia: new insights and future directions. JCSM Clin Reports 2:1–17. https://doi.org/10.17987/jcsm-cr.v2i2.45
McCullough MJ, Peplinski NG, Kinnell KR, Spitsbergen JM (2011) Glial cell line-derived neurotrophic factor (GDNF) protein content in rat skeletal muscle is altered by increased physical activity in vivo and in vitro. Neuroscience 174:234–244. https://doi.org/10.1016/j.neuroscience.2010.11.016
McKay BR, Ogborn DI, Bellamy LM et al (2012) Myostatin is associated with age-related human muscle stem cell dysfunction. FASEB J 26:2509–2521. https://doi.org/10.1096/fj.11-198663
Ming Y, Bergman E, Edström E, Ulfhake B (1999) Evidence for increased GDNF signaling in aged sensory and motor neurons. Neuroreport 10:1529–1535. https://doi.org/10.1097/00001756-199905140-00025
Miyazaki S, Iino N, Koda R et al (2020) Brain-derived neurotrophic factor is associated with sarcopenia and frailty in Japanese hemodialysis patients. Geriatr Gerontol Int. https://doi.org/10.1111/ggi.14089
Moore DR, Churchward-Venne TA, Witard O et al (2015) Protein ingestion to stimulate myofibrillar protein synthesis requires greater relative protein intakes in healthy older versus younger men. Journals Gerontol - Ser A Biol Sci Med Sci 70:57–62. https://doi.org/10.1093/gerona/glu103
Moreira-Pais A, Ferreira R, da Costa RG (2018) Platinum-induced muscle wasting in cancer chemotherapy: mechanisms and potential targets for therapeutic intervention. Life Sci 208:1–9. https://doi.org/10.1016/j.lfs.2018.07.010
Morissette MR, Stricker JC, Rosenberg MA et al (2009) Effects of myostatin deletion in aging mice. Aging Cell 8:573–583. https://doi.org/10.1111/j.1474-9726.2009.00508.x
Morley JE (2008) Sarcopenia: diagnosis and treatment. J Nutr Heal Aging 12:452–456. https://doi.org/10.1007/BF02982705
Mosole S, Carraro U, Kern H et al (2014) Long-term high-level exercise promotes muscle reinnervation with age. J Neuropathol Exp Neurol 73:284–294. https://doi.org/10.1097/NEN.0000000000000032
Muñoz-Cánoves P, Scheele C, Pedersen BK, Serrano AL (2013) Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword ? FEBS J 280:4131–4148. https://doi.org/10.1111/febs.12338
Murphy KT, Koopman R, Naim T et al (2010) Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. FASEB J 24:4433–4442. https://doi.org/10.1096/fj.10-159608
O’Connor KG, Tobin JD, Harman SM et al (1998) Serum levels of insulin-like growth factor-I are related to age and not to body composition in healthy women and men. J Gerontol - Ser A Biol Sci Med Sci 53:M176–M182. https://doi.org/10.1093/gerona/53A.3.m176
Oeckinghaus A, Ghosh S (2009) The NF-κB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 1:a000034. https://doi.org/10.1101/cshperspect.a000034
Olsen M, Krog L, Edvardsen K et al (1993) Intact transmembrane isoforms of the neural cell adhesion molecule are released from the plasma membrane. Biochem J 295:833–840. https://doi.org/10.1042/bj2950833
Op den Kamp CM, Langen RC, Snepvangers FJ et al (2013) Nuclear transcription factor κB activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia. Am J Clin Nutr 98:738–748. https://doi.org/10.3945/ajcn.113.058388
Ozawa T (2010) Modulation of ryanodine receptor Ca2 + channels (Review). Mol Med Rep 3:199–204. https://doi.org/10.3892/mmr_00000240
Park B, You S, Cho WCS et al (2019) A systematic review of herbal medicines for the treatment of cancer cachexia in animal models. J Zhejiang Univ Sci B 20:9–22. https://doi.org/10.1631/jzus.B1800171
Penna F, Busquets S, Pin F et al (2011) Combined approach to counteract experimental cancer cachexia: eicosapentaenoic acid and training exercise. J Cachexia Sarcopenia Muscle 2:95–104. https://doi.org/10.1007/s13539-011-0028-4
Peterson SJ, Mozer M (2017) Differentiating sarcopenia and cachexia among patients with cancer. Nutr Clin Pract 32:30–39. https://doi.org/10.1177/0884533616680354
Piasecki M, Ireland A, Piasecki J et al (2018) Failure to expand the motor unit size to compensate for declining motor unit numbers distinguishes sarcopenic from non-sarcopenic older men. J Physiol 596:1627–1637. https://doi.org/10.1113/JP275520
Ratkevicius A, Joyson A, Selmer I et al (2011) Serum concentrations of myostatin and myostatin-interacting proteins do not differ between young and sarcopenic elderly men. J Gerontol - Ser A 66A:620–626. https://doi.org/10.1093/gerona/glr025
Rivas DA, Morris EP, Haran PH et al (2012) Increased ceramide content and NFκB signaling may contribute to the attenuation of anabolic signaling after resistance exercise in aged males. J Appl Physiol 113:1727–1736. https://doi.org/10.1152/japplphysiol.00412.2012
Roberts BM, Frye GS, Ahn B et al (2013) Cancer cachexia decreases specific force and accelerates fatigue in limb muscle. Biochem Biophys Res Commun 435:488–492. https://doi.org/10.1016/j.bbrc.2013.05.018
Roberts BM, Lavin KM, Many GM et al (2018) Human neuromuscular aging: sex differences revealed at the myocellular level. Exp Gerontol 106:116–124. https://doi.org/10.1016/j.exger.2018.02.023
Robinson SM, Reginster JY, Rizzoli R et al (2018) Does nutrition play a role in the prevention and management of sarcopenia? Clin Nutr 37:1121–1132. https://doi.org/10.1016/j.clnu.2017.08.016
Rolland Y, Onder G, Morley JE et al (2011) Current and future pharmacologic treatment of sarcopenia. Clin Geriatr Med 27:423–447. https://doi.org/10.1016/j.cger.2011.03.008
Rondanelli M, Miccono A, Peroni G et al (2016) A systematic review on the effects of botanicals on skeletal muscle health in order to prevent sarcopenia. Evidence-based Complement Altern Med 2016:5970367. https://doi.org/10.1155/2016/5970367
Rooks D, Roubenoff R (2019) Development of pharmacotherapies for the treatment of sarcopenia. J Frailty Aging 8:120–130. https://doi.org/10.14283/jfa.2019.11
Rowan SL, Rygiel K, Purves-Smith FM et al (2012) Denervation causes fiber atrophy and myosin heavy chain co-expression in senescent skeletal muscle. PLoS One 7:e29082. https://doi.org/10.1371/journal.pone.0029082
Rudolf R, Khan MM, Labeit S, Deschenes MR (2014) Degeneration of neuromuscular junction in age and dystrophy. Front Aging Neurosci. https://doi.org/10.3389/fnagi.2014.00099
Russ DW, Grandy JS, Toma K, Ward CW (2011) Ageing, but not yet senescent, rats exhibit reduced muscle quality and sarcoplasmic reticulum function. Acta Physiol 201:391–403. https://doi.org/10.1111/j.1748-1716.2010.02191.x
Santilli V, Bernetti A, Mangone M, Paoloni M (2014) Clinical definition of sarcopenia. Clin Cases Miner Bone Metab 11:177–180
Schaap LA, Pluijm SMF, Deeg DJH et al (2009) Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength. J Gerontol - Ser A Biol Sci Med Sci 64A:1183–1189. https://doi.org/10.1093/gerona/glp097
Schmidt SF, Rohm M, Herzig S, Berriel Diaz M (2018) Cancer cachexia: more than skeletal muscle wasting. Trends in Cancer 4:849–860. https://doi.org/10.1016/j.trecan.2018.10.001
Sebastián D, Sorianello E, Segalés J et al (2016) Mfn2 deficiency links age-related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway. EMBO J 35:1677–1693. https://doi.org/10.15252/embj.201593084
Secher T (2010) Soluble NCAM. In: Berezin V (ed) Structure and function of the neural cell adhesion molecule NCAM. Springer, Verlag-New York, pp 227–242
Serra-Prat M, Papiol M, Monteis R et al (2015) Relationship between plasma ghrelin levels and sarcopenia in elderly subjects: a cross-sectional study. J Nutr Heal Aging 19:669–672. https://doi.org/10.1007/s12603-015-0550-8
Smiechowska J, Utech A, Taffet G et al (2010) Adipokines in patients with cancer anorexia and cachexia. J Investig Med 58:554–559. https://doi.org/10.2310/JIM.0b013e3181cf91ca
Smith GI, Julliand S, Reeds DN et al (2015) Fish oil-derived n-3 PUFA therapy increases muscle mass and function in healthy older adults. Am J Clin Nutr 102:115–122. https://doi.org/10.3945/ajcn.114.105833
Snijders T, Nederveen JP, McKay BR et al (2015) Satellite cells in human skeletal muscle plasticity. Front Physiol 6:283. https://doi.org/10.3389/fphys.2015.00283
St-Jean-Pelletier F, Pion CH, Leduc-Gaudet JP et al (2017) The impact of ageing, physical activity, and pre-frailty on skeletal muscle phenotype, mitochondrial content, and intramyocellular lipids in men. J Cachexia Sarcopenia Muscle 8:213–228. https://doi.org/10.1002/jcsm.12139
Stevens L, Firinga C, Gohlsch B et al (2000) Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat. Am J Physiol - Cell Physiol 279:C1558–C1563. https://doi.org/10.1152/ajpcell.2000.279.5.c1558
Storer TW, Basaria S, Traustadottir T et al (2017) Effects of testosterone supplementation for 3-years on muscle performance and physical function in older men. J Clin Endocrinol Metab 102:583–593. https://doi.org/10.1210/jc.2016-2771
Taetzsch T, Tenga MJ, Valdez G (2017) Muscle fibers secrete FGFBP1 to slow degeneration of neuromuscular synapses during aging and progression of ALS. J Neurosci 37:70–82. https://doi.org/10.1523/JNEUROSCI.2992-16.2016
Talmadge RJ (2000) Myosin heavy chain isoform expression following reduced neuromuscular activity: potential regulatory mechanisms. Muscle Nerve 23:661–679
Tanaka M, Sugimoto K, Fujimoto T et al (2019) Preventive effects of low-intensity exercise on cancer cachexia–induced muscle atrophy. FASEB J 33:7852–7862. https://doi.org/10.1096/fj.201802430R
Taskin S, Stumpf VI, Bachmann J et al (2014) Motor protein function in skeletal abdominal muscle of cachectic cancer patients. J Cell Mol Med 18:69–79. https://doi.org/10.1111/jcmm.12165
Tomlinson BE, Irving D (1977) The numbers of limb motor neurons in the human lumbosacral cord throughout life. J Neurol Sci 34:213–219
Townsend JR, Hoffman JR, Fragala MS et al (2016) A microbiopsy method for immunohistological and morphological analysis: a pilot study. Med Sci Sports Exerc 48:331–335. https://doi.org/10.1249/MSS.0000000000000772
Troiano AR, Schulzer M, De La Fuente-Fernandez R et al (2010) Dopamine transporter PET in normal aging: dopamine transporter decline and its possible role in preservation of motor function. Synapse 64:146–151. https://doi.org/10.1002/syn.20708
Tsay H-J, Schmidt J (1989) Skeletal muscle denervation activates acetylcholine receptor genes. J Cell Biol 108:1523–1526. https://doi.org/10.1083/jcb.108.4.1523
Uchitomi R, Hatazawa Y, Senoo N et al (2019) Metabolomic analysis of skeletal muscle in aged mice. Sci Rep 9:10425. https://doi.org/10.1038/s41598-019-46929-8
Valdez G, Tapia JC, Kang H et al (2010) Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise. Proc Natl Acad Sci U S A 107:14863–14868. https://doi.org/10.1073/pnas.1002220107
Veyrat-Durebex C, Quirion R, Ferland G et al (2013) Aging and long-term caloric restriction regulate neuropeptide Y receptor subtype densities in the rat brain. Neuropeptides 47:163–169. https://doi.org/10.1016/j.npep.2013.01.001
Visser M, Pahor M, Taaffe DR et al (2002) Relationship of interleukin-6 and tumor necrosis factor-α with muscle mass and muscle strength in elderly men and women: the health ABC study. J Gerontol - Ser A Biol Sci Med Sci 57A:M326–M332. https://doi.org/10.1093/gerona/57.5.m326
Wåhlin-Larsson B, Carnac G, Kadi F (2014) The influence of systemic inflammation on skeletal muscle in physically active elderly women. Age (Omaha) 36:9718. https://doi.org/10.1007/s11357-014-9718-0
Wåhlin-Larsson B, Wilkinson DJ, Strandberg E et al (2017) Mechanistic links underlying the impact of c-reactive protein on muscle mass in elderly. Cell Physiol Biochem 44:267–278. https://doi.org/10.1159/000484679
Weryńska B, Kosacka M, Gołecki M, Jankowska R (2009) Leptin serum levels in cachectic and non-cachectic lung cancer patients. Adv Respir Med 77:500–506
Wesley Peixoto da Fonseca G, Farkas J, Dora E et al (2020) Cancer cachexia and related metabolic dysfunction. Int J Mol Sci 21:2321. https://doi.org/10.3390/ijms21072321
Westbury LD, Fuggle NR, Syddall HE et al (2018) Relationships between markers of inflammation and muscle mass, strength and function: findings from the Hertfordshire Cohort Study. Calcif Tissue Int 102:287–295. https://doi.org/10.1007/s00223-017-0354-4
Wham CA, Bowden JA (2011) Eating for health: perspectives of older men who live alone. Nutr Diet 68:221–226. https://doi.org/10.1111/j.1747-0080.2011.01535.x
White JP, Baynes JW, Welle SL et al (2011) The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc Min/+ mouse. PLoS One 6:e24650. https://doi.org/10.1371/journal.pone.0024650
Wilkinson DJ, Piasecki M, Atherton PJ (2018) The age-related loss of skeletal muscle mass and function: measurement and physiology of muscle fibre atrophy and muscle fibre loss in humans. Ageing Res Rev 47:123–132. https://doi.org/10.1016/j.arr.2018.07.005
Winter A, MacAdams J, Chevalier S (2012) Normal protein anabolic response to hyperaminoacidemia in insulin-resistant patients with lung cancer cachexia. Clin Nutr 31:765–773. https://doi.org/10.1016/j.clnu.2012.05.003
Wu J, Huang C, Xiao H et al (2013) Weight loss and resting energy expenditure in male patients with newly diagnosed esophageal cancer. Nutrition 29:1310–1314. https://doi.org/10.1016/j.nut.2013.04.010
Wyczalkowska-Tomasik A, Czarkowska-Paczek B, Zielenkiewicz M, Paczek L (2016) Inflammatory markers change with age, but do not fall beyond reported normal ranges. Arch Immunol Ther Exp (Warsz) 64:249–254. https://doi.org/10.1007/s00005-015-0357-7
Xia Z, Cholewa J, Zhao Y et al (2017) Targeting inflammation and downstream protein metabolism in sarcopenia: a brief up-dated description of concurrent exercise and leucine-based multimodal intervention. Front Physiol 8:434. https://doi.org/10.3389/fphys.2017.00434
Yarasheski KE, Bhasin S, Sinha-Hikim I et al (2002) Serum myostatin-immunoreactive protein is increased in 60–92 year old women and men with muscle wasting. J Nutr Heal Aging 6:343–348
Yazar T, Olgun Yazar H (2019) Prevalance of sarcopenia according to decade. Clin Nutr ESPEN 29:137–141. https://doi.org/10.1016/j.clnesp.2018.11.005
Zhao K, Shen C, Li L et al (2018) Sarcoglycan alpha mitigates neuromuscular junction decline in aged mice by stabilizing LRP4. J Neurosci 38:8860–8873. https://doi.org/10.1523/JNEUROSCI.0860-18.2018
Acknowledgements
This work was supported by CIAFEL (UIDB/00617/2020), LAQV (UIDB/50006/2020) and CITAB (UIDB/04033/2020) research units and by A.M.P.’s fellowship (SFRH/BD/144396/2019) through national founds by the Portuguese Foundation for Science and Technology (FCT) and co-financed by the European Regional Development Fund (FEDER), within the PT2020 Partnership Agreement.
Author information
Authors and Affiliations
Contributions
AMP conducted the literature search and drafted the manuscript and PAO, RF and JAD critically revised the work.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
Not applicable.
Consent for publication
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Moreira-Pais, A., Ferreira, R., Oliveira, P.A. et al. Sarcopenia versus cancer cachexia: the muscle wasting continuum in healthy and diseased aging. Biogerontology 22, 459–477 (2021). https://doi.org/10.1007/s10522-021-09932-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10522-021-09932-z